Evidence map›Paper›PMID 42814966›Full record

ReviewJMIR diabetes2026

Real-Time Psychological Factors Using Ecological Momentary Assessment With Continuous Glucose Monitoring in Diabetes Mellitus: Scoping Review.

Kara Mizokami-Stout, Kira Voelker, Melissa DeJonckheere, Lynn Ang, Evan L Reynolds, Joyce M Lee, Rodica Pop-Busui, Brian C Callaghan, Emily Hirschfeld, Jennifer J Iyengar and 1 more

Abstract readReview
In one paragraph

Review in JMIR diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kara Mizokami-Stout *Division of Metabolism, Endocrinology and Diabetes, University of Michigan, 1000 Wall Street, Ann Arbor, MI, 48105, United States, 1 734-232-1269.ORCID http://orcid.org/0000-0002-6933-2586
Kira Voelker *Parkview Mirro Center for Research and Innovation, Fort Wayne, IN, United States.ORCID http://orcid.org/0009-0005-1084-6119
Melissa DeJonckheereDepartment of Family Medicine, University of Michigan, Ann Arbor, MI, United States.ORCID http://orcid.org/0000-0002-2660-3358
Lynn AngDivision of Metabolism, Endocrinology and Diabetes, University of Michigan, 1000 Wall Street, Ann Arbor, MI, 48105, United States, 1 734-232-1269.ORCID http://orcid.org/0000-0001-7133-9886
Evan L ReynoldsDepartment of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, United States.ORCID http://orcid.org/0000-0002-0138-8436
Joyce M LeeDivision of Pediatric Endocrinology, University of Michigan, Ann Arbor, MI, United States.ORCID http://orcid.org/0000-0002-8147-5168
Rodica Pop-BusuiDivision of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health and Science University Hospital, Portland, OR, United States.ORCID http://orcid.org/0000-0002-2042-1350
Brian C CallaghanDepartment of Endocrinology and Metabolism, VA Ann Arbor Healthcare System, Ann Arbor, MI, United States.ORCID http://orcid.org/0000-0002-8885-6748
Emily HirschfeldSusan B. Meister Child Health Evaluation and Research Center, University of Michigan, Ann Arbor, MI, United States.ORCID http://orcid.org/0009-0006-5307-8348
Jennifer J IyengarDivision of Metabolism, Endocrinology and Diabetes, University of Michigan, 1000 Wall Street, Ann Arbor, MI, 48105, United States, 1 734-232-1269.ORCID http://orcid.org/0000-0001-6929-1836
Dana AlbrightParkview Mirro Center for Research and Innovation, Fort Wayne, IN, United States.ORCID http://orcid.org/0000-0002-6394-6763

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Karen Eileen Peterson · 2010 to 2026
$20.3M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
Support to Adopt and Retain Technology (StART) CGM: A pilot study to support continuous glucose monitoring in primary careK23DK131296 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kara R Mizokami-Stout · 2022 to 2026
$970k
Predicting complications of diabetes with longitudinal metabolic trajectoriesR00DK129785 · NIDDK · HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES · PI Evan L Reynolds · 2024 to 2026
$745k
Optimizing Use of Advanced Diabetes Technology for Self-Management in Adolescents with Type 1 Diabetes: Integration of Real-Time Glucose and Narrative DataK01DK134766 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Melissa DeJonckheere · 2023 to 2026
$627k
NIDDK NIH HHS K01 DK134766NIDDK NIH HHS K23 DK131296NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK089503NIDDK NIH HHS P30 DK092926NIDDK NIH HHS R00 DK129785
6 · The paper itself

Abstract

Background: Ecological momentary assessment (EMA) is a tool that captures emotional states, experiences, and behaviors in real or near-real time. Concurrent EMA and continuous glucose monitoring (CGM) data can provide an in-depth understanding of the impacts of psychosocial factors on momentary glucose levels. However, study methodology varies widely for EMA and CGM data collection and analysis. Objective: This scoping review aims to summarize the objectives, methodologies, and outcomes of studies analyzing concurrent biopsychosocial EMA and CGM data in diabetes. Methods: This study was conducted following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. Original research studies evaluating participants with diabetes, with concurrent collection and analysis of EMA and CGM data, were included in this review. A total of 782 studies were identified from PubMed, Embase, and EBSCOhost from May 2009 to December 2025. From these, duplicates, non-original research articles, and articles not measuring concurrent EMA and CGM data were excluded, resulting in a total of 19 studies included in this review. Methodological data were abstracted and summarized, including study characteristics, EMA protocols and outcomes, CGM outcomes, and integrated EMA and CGM study objectives. Methodological gaps across the included studies were identified and summarized. Results: Of the 19 studies, 16 primarily recruited adult populations, and the majority of these studies (n=14, 74%) included participants with type 1 diabetes. The median EMA delivery duration was 14 days (range 3-18 days), with a median of 5.5 prompts delivered per day (range 1-28). EMA outcomes included a variety of biopsychosocial factors (emotion, self-care behaviors, interpersonal interactions, symptoms, and cognition). Seventy-four percent analyzed blinded CGM data over a median of 14 (range 3-18) days. Forty-two percent used nonstandardized CGM glucose outcomes (postprandial glucose, eating patterns, and hypoglycemic events). Integrated EMA and CGM data analysis answered a broad array of study objectives, including the impact of psychosocial factors on momentary glucose metrics; the influence of momentary glucose on emotional states, mood, personal behaviors, sleep, and cognition, or vice versa; and study protocol or mobile app optimization, among others. Methodological gaps included lack of standardization of EMA and CGM outcomes, duration of data capture, reporting of statistical analyses, and study population. Conclusions: This review provides a detailed summary of the methodology and outcomes of original research articles using combined EMA and blood glucose data measured via CGM. These combined methods allow for an opportunity to elucidate relationships between psychosocial factors and momentary glucose, an understanding of which is imperative for the development of future psychological and behavioral interventions in diabetes. However, standardization of protocols and expansion of participant populations for future EMA and CGM data collection and analysis are needed to ensure data accuracy, reproducibility, and generalizability.

Indexed as

behavioral factorscontinuous glucose monitoringdiabetes mellitusecological momentary assessmentglucose monitoringpsychosocial factors

Identifiers

PMID42814966
PMCPMC13626547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.